NCT02637180

Brief Summary

This is multiple center, prospective study aiming to investigate the tracking and outcome of patients attending Greek General hospitals with low-trauma fractures. Secondary end-points were to facilitate the implementation of coordinated, multi-disciplinary models of care for secondary fracture prevention, and to monitor osteoporosis treatment initiation, osteoporosis treatment persistence at 12 months, compliance, and subsequent fractures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
397

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2015

Typical duration for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 22, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2017

Completed
Last Updated

February 23, 2018

Status Verified

February 1, 2018

Enrollment Period

2.7 years

First QC Date

December 12, 2015

Last Update Submit

February 22, 2018

Conditions

Keywords

osteoporosisfractureliaison service

Outcome Measures

Primary Outcomes (1)

  • Participation rate in the FLS program

    Participation rate in the FLS program of patients with low-trauma fractures

    2 years

Secondary Outcomes (3)

  • Percentage of patients initiating osteoporosis treatment

    2 years

  • percentage of patients experiencing subsequent fractures

    2 years

  • osteoporosis treatment adherence at 24 months [measured by Medication Possession Ratio (MPR)]

    2 years

Study Arms (1)

patients with low-energy fracture(s)

The study will include patients from pre-defined groups of individuals (postmenopausal, perimenopausal, male, and steroid induced osteoporosis) who would be anyway eligible to receive treatment for their condition according to standard medical practice and Greek treatment guidelines. Drug: anti-osteoporotic medication (bisphosphonates, denosumab, strontium ranelate, teriparatide, SERMs)

Drug: anti-osteoporotic medication

Interventions

check previous information

Also known as: all available anti-osteoporotic medication
patients with low-energy fracture(s)

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 50 years old with low energy fractures

You may qualify if:

  • Hospitalized patients and Outpatients over 50 years old with low energy fractures (low energy fracture is defined as a fracture resulting from minimal trauma such as falling from standing height or less).

You may not qualify if:

  • Presence of osteomalacia and/or other clinical entities predisposing to low energy fractures, apart from osteoporosis, such as primary or secondary hyperparathyroidism, Paget's disease of bone, osteogenesis imperfecta and paraplegia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, MEDICAL SCHOOL, 2nd DEPARTMENT OF ORTHOPAEDIC SURGERY

Athens, Attica, 14233, Greece

Location

Democritus University of Thrace, School of Medicine, Department of Orthopaedic Surgery

Alexandroupoli, Evros, 68100, Greece

Location

Orthopaedic Department, Faculty of Medicine, School of Health Sciences, University of Thessalia

Larissa, 41110, Greece

Location

Aristotle University of Thessaloniki, 3rd University Orthopaedic Department, Papageorgiou General Hospital

Thessaloniki, 56403, Greece

Location

Related Publications (5)

  • Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML, McLellan AR, Mitchell PJ, Sale JE, Wahl DA; IOF CSA Fracture Working Group. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int. 2011 Jul;22(7):2051-65. doi: 10.1007/s00198-011-1642-x. Epub 2011 May 24.

    PMID: 21607807BACKGROUND
  • McLellan AR, Gallacher SJ, Fraser M, McQuillian C. The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int. 2003 Dec;14(12):1028-34. doi: 10.1007/s00198-003-1507-z. Epub 2003 Nov 5.

    PMID: 14600804BACKGROUND
  • Cooper MS, Palmer AJ, Seibel MJ. Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int. 2012 Jan;23(1):97-107. doi: 10.1007/s00198-011-1802-z. Epub 2011 Sep 28.

    PMID: 21953475BACKGROUND
  • Makras P, Vaiopoulos G, Lyritis GP; Greek National Medicine Agency. 2011 guidelines for the diagnosis and treatment of osteoporosis in Greece. J Musculoskelet Neuronal Interact. 2012 Mar;12(1):38-42. No abstract available.

    PMID: 22373950BACKGROUND
  • Dehamchia-Rehailia N, Ursu D, Henry-Desailly I, Fardellone P, Paccou J. Secondary prevention of osteoporotic fractures: evaluation of the Amiens University Hospital's fracture liaison service between January 2010 and December 2011. Osteoporos Int. 2014 Oct;25(10):2409-16. doi: 10.1007/s00198-014-2774-6. Epub 2014 Jul 1.

    PMID: 24980182BACKGROUND

MeSH Terms

Conditions

OsteoporosisFractures, Bone

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesWounds and Injuries

Study Officials

  • Christos Kosmidis, MD, Phd

    Hellenic Society for the Study of Bone Metabolism

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2015

First Posted

December 22, 2015

Study Start

April 1, 2015

Primary Completion

December 7, 2017

Study Completion

December 7, 2017

Last Updated

February 23, 2018

Record last verified: 2018-02

Locations